Trials / Completed
CompletedNCT01160081
Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis
Sero-prevalence of Hepatitis A Varicella-Zoster Virus, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis in Mexico
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,658 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 1 Year – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the seroprevalence of Hepatitis A Virus (HAV), Varicella-Zoster virus (VZV), Cytomegalovirus (CMV), Herpes Simplex (HSV) and Bordetella pertussis (BP)infections in Mexico.
Detailed description
In order to document the epidemiological changes in the sero-prevalence of Hepatitis A, Human simplex virus (1 and 2), Varicella-Zoster virus and Cytomegalovirus infections, we propose to conduct a population based, seroprevalence, cross-sectional study, in Mexico. This will allow the identification of susceptible populations, which in turn, will serve as evidence for the elaboration of recommendations for the prevention of Hepatitis A, Human simplex virus, Varicella-Zoster virus and Cytomegalovirus infection in the region. This study was conducted using data and serum samples from a random sample of subjects that participated in the 2006 National Health and Nutrition Survey.
Conditions
- Viral Hepatitis Vaccines
- Hepatitis A
- Cytomegalovirus
- Varicella-Zoster Virus
- Bordetella Pertussis Infection
- Herpes Simplex (1 and 2)
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Serum sample | Serum samples collected |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2010-07-12
- Last updated
- 2011-01-25
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT01160081. Inclusion in this directory is not an endorsement.